We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The government is collaborating with pharmaceutical company Novartis to launch a clinical trial for new cholesterol treatment.
First published during the 2015 to 2016 Cameron Conservative government
An exchange of letters between the Paymaster General, The Rt Hon Michael Ellis QC MP, and Sir Robert Francis QC - Terms of Reference for the Infected Blood Compensation Framework Study
How the rules around blood donation will change for some groups of people, following a clinical study with recommendations.
First published during the 2016 to 2019 May Conservative government
Our experts describe some of their incredible innovative work, putting the science inside UK defence and security.
Naphyrone – often advertised as 'NRG1' – and its related compounds are to be banned and made Class B drugs, minister for crime prevention James Brokenshire announced today.
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Advisory Council on the Misuse of Drugs recommends that naphyrone, often marketed as the 'legal high' NRG-1, should be made a Class B drug.
Upper Tribunal Administrative Appeals Chamber decision by Judge Jacobs on 12 April 2023.
No evidence of any UK clinical cases of variant Creutzfeldt-Jakob Disease (vCJD) being linked to a blood transfusion given after 1999.
Updated guidance for staying safe on the water
The Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) has today published a position statement on the provision of cytomegalovirus tested blood components, together with a more detailed report.
Employment Tribunal decision.
Patients to have better access and greater control over their health and care data under new proposals.
First published during the 2019 to 2022 Johnson Conservative government
Organisations across the UK will get funding to develop new treatments and technologies that could transform patients’ lives.
NRG-1, should be made a Class B drug, recommends the Advisory Council on the Misuse of Drugs (ACMD) in its advice to government.
In patients at risk for aortic aneurysm and dissection, fluoroquinolones should only be used after careful assessment of the benefits and risks and after consideration of other therapeutic options.
The Department of Health today published a report on NHS Blood and Transplant (NHSBT)
The Department has issued an Estates and Facilities Alert relating to an uncontrolled release of liquid oxygen from a VIE device, installed …
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).